Davelizomib
Davelizomib is proteasome inhibitor with antineoplastic effect[1].
Product Specifications
CAS Number
2409841-51-4
UNSPSC
12352005
Target
Proteasome
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/davelizomib.html
Solubility
10 mM in DMSO
Smiles
CC(C)C[C@@H](B1O[C@H](C(O1)=O)CC(O)=O)NC(CNC([C@H]2N(C3=C(C=C(C=C3)F)F)CC2)=O)=O
Molecular Formula
C21H26BF2N3O7
Molecular Weight
481.25
References & Citations
[1]Xiong, et al. Preparation and medicinal application of borates of azetidine derivatives. World Intellectual Property Organization, WO2020025037 A1. 2020-02-06.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
![PerCP/Cyanine5.5 Mouse IgG2b, κ Isotype Control[MPC-11]](https://cdn.genprice.uk/products/763/68dd149c061270361e7cf635/imageurl/e-ab-f09813j.webp)
E-AB-F09813J-01 25 µg
PerCP/Cyanine5.5 Mouse IgG2b, κ Isotype Control[MPC-11]
Sign In for Pricing
View Details E-AB-F09813J-02 100 µg
PerCP/Cyanine5.5 Mouse IgG2b, κ Isotype Control[MPC-11]
Sign In for Pricing
View Details 
